Kanji Nakatsu, Professor Emeritus of Pharmacology at Queen’s University, discusses the potential importance of stress proteins in COVID-19 and how
A group of concerned doctors and other healthcare professionals from the Okanagan region of British Columbia have written a powerful,
A new petition supporting the recognition and wide availability of Ivermectin for prophylaxis and early outpatient treatment of COVID-19 has
We represent over 500 members, comprised of physicians, research scientists (including virologists, vaccinologists, and immunologists), and others; including highly accomplished
The number of daily cases of coronavirus disease (Covid-19) have been on a downswing in Uttar Pradesh. The key parts
Zinc is known to play a central role in the immune system and zinc-deficient persons experience increased susceptibility to a
A practical approach to home-based care for healthy families
Multiple studies from around the world note that there is an inverse association between vitamin D levels and severity of
Evaluation of Fluvoxamine as an effective prophylactic and treatment drug for COVID-19.
A pharmaceutical company in Vancouver, Canada called SaNOtize, has been developing topical antimicrobial products to help fight drug resistant infections,
In this brief, we recommend that ivermectin should be considered as a suitable candidate for early out-patient treatment for COVID-19,
Dr. David Chesler recounts the success he’s had treating nursing home patients with Ivermectin.
